Exact Sciences (EXAS) EBT (2010 - 2025)

Exact Sciences (EXAS) has 16 years of EBT data on file, last reported at -$85.1 million in Q4 2025.

• EBT for Q4 2025 came in at -$85.1 million, up 90.29% year-over-year; the trailing twelve-month figure through Dec 2025 was -$203.9 million (up 80.32% YoY), and the FY2025 annual result was -$203.9 million, up 80.32% from the prior year.
• EBT eased to -$85.1 million in Q4 2025 per EXAS's latest filing, from -$17.8 million in the prior quarter.
• Over five years, EBT peaked at $1.0 million in Q3 2023 and troughed at -$876.0 million in Q4 2024.
• A 5-year average of -$145.8 million and a median of -$104.7 million in 2024 frame the typical range for EBT.
• The sharpest annual moves came in 2023 and 2024: EBT soared 100.69% in 2023, then plunged 3688.49% in 2024.
• A 5-year view of EBT shows it stood at -$224.9 million in 2021, then surged by 42.22% to -$129.9 million in 2022, then jumped by 61.23% to -$50.4 million in 2023, then sank by 1638.86% to -$876.0 million in 2024, then soared by 90.29% to -$85.1 million in 2025.
• Business Quant data shows EXAS's EBT at -$85.1 million in Q4 2025, -$17.8 million in Q3 2025, and -$57000.0 in Q2 2025.